364 related articles for article (PubMed ID: 11375370)
1. Lipid and blood pressure treatment goals for type 1 diabetes: 10-year incidence data from the Pittsburgh Epidemiology of Diabetes Complications Study.
Orchard TJ; Forrest KY; Kuller LH; Becker DJ;
Diabetes Care; 2001 Jun; 24(6):1053-9. PubMed ID: 11375370
[TBL] [Abstract][Full Text] [Related]
2. Incidence of complications in insulin-dependent diabetes mellitus: a survival analysis.
Lloyd CE; Becker D; Ellis D; Orchard TJ
Am J Epidemiol; 1996 Mar; 143(5):431-41. PubMed ID: 8610658
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein subclass measurements by nuclear magnetic resonance spectroscopy improve the prediction of coronary artery disease in Type 1 diabetes. A prospective report from the Pittsburgh Epidemiology of Diabetes Complications Study.
Soedamah-Muthu SS; Chang YF; Otvos J; Evans RW; Orchard TJ;
Diabetologia; 2003 May; 46(5):674-82. PubMed ID: 12743701
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.
Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group
Diabetes Care; 1999 Jan; 22(1):99-111. PubMed ID: 10333910
[TBL] [Abstract][Full Text] [Related]
5. The progression of retinopathy over 2 years: the Pittsburgh Epidemiology of Diabetes Complications (EDC) Study.
Lloyd CE; Klein R; Maser RE; Kuller LH; Becker DJ; Orchard TJ
J Diabetes Complications; 1995; 9(3):140-8. PubMed ID: 7548977
[TBL] [Abstract][Full Text] [Related]
6. Spontaneous whole blood platelet aggregation, hematological variables and complications in insulin-dependent diabetes mellitus: the Pittsburgh Epidemiology of Diabetes Complications Study.
Cho NH; Becker DJ; Ellis D; Kuller LH; Drash AL; Orchard TJ
J Diabetes Complications; 1992; 6(1):12-8. PubMed ID: 1562753
[TBL] [Abstract][Full Text] [Related]
7. Occurrence and interrelationships of complications in insulin-dependent diabetes in Finland.
Ebeling P; Koivisto VA
Acta Diabetol; 1997 Mar; 34(1):33-8. PubMed ID: 9134055
[TBL] [Abstract][Full Text] [Related]
8. Reversed circadian blood pressure rhythm is associated with occurrences of both fatal and nonfatal vascular events in NIDDM subjects.
Nakano S; Fukuda M; Hotta F; Ito T; Ishii T; Kitazawa M; Nishizawa M; Kigoshi T; Uchida K
Diabetes; 1998 Sep; 47(9):1501-6. PubMed ID: 9726241
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein(a) concentration shows little relationship to IDDM complications in the Pittsburgh Epidemiology of Diabetes Complications Study cohort.
Maser RE; Usher D; Becker DJ; Drash AL; Kuller LH; Orchard TJ
Diabetes Care; 1993 May; 16(5):755-8. PubMed ID: 8495616
[TBL] [Abstract][Full Text] [Related]
10. Optimal glycaemic and blood pressure but not lipid targets are related to a lower prevalence of diabetic microvascular complications.
Bashir M; Elhadd T; Dabbous Z; Gul W; Salameh O; Siddiqui M; Al-Muhannadi H; Petropoulos I; Khan A; Ponirakis G; Malik RA
Diabetes Metab Syndr; 2021; 15(5):102241. PubMed ID: 34390975
[TBL] [Abstract][Full Text] [Related]
11. The impact of serum lipids on risk for microangiopathy in patients with type 2 diabetes mellitus.
Toth PP; Simko RJ; Palli SR; Koselleck D; Quimbo RA; Cziraky MJ
Cardiovasc Diabetol; 2012 Sep; 11():109. PubMed ID: 22978715
[TBL] [Abstract][Full Text] [Related]
12. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.
Ohkubo Y; Kishikawa H; Araki E; Miyata T; Isami S; Motoyoshi S; Kojima Y; Furuyoshi N; Shichiri M
Diabetes Res Clin Pract; 1995 May; 28(2):103-17. PubMed ID: 7587918
[TBL] [Abstract][Full Text] [Related]
13. Glycaemic control and microvascular complications in a large cohort of Italian Type 1 diabetic out-patients.
Lepore G; Bruttomesso D; Nosari I; Tiengo A; Trevisan R
Diabetes Nutr Metab; 2002 Aug; 15(4):232-9. PubMed ID: 12416660
[TBL] [Abstract][Full Text] [Related]
14. Renal and retinal microangiopathy after 15 years of follow-up study in a sample of Type 1 diabetes mellitus patients.
Romero P; Salvat M; Fernández J; Baget M; Martinez I
J Diabetes Complications; 2007; 21(2):93-100. PubMed ID: 17331857
[TBL] [Abstract][Full Text] [Related]
15. The influence of pregnancy on IDDM complications.
Hemachandra A; Ellis D; Lloyd CE; Orchard TJ
Diabetes Care; 1995 Jul; 18(7):950-4. PubMed ID: 7555555
[TBL] [Abstract][Full Text] [Related]
16. The 30-year natural history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes Complications Study experience.
Pambianco G; Costacou T; Ellis D; Becker DJ; Klein R; Orchard TJ
Diabetes; 2006 May; 55(5):1463-9. PubMed ID: 16644706
[TBL] [Abstract][Full Text] [Related]
17. Predictors of mortality and end-stage diabetic complications in patients with Type 1 diabetes mellitus on intensified insulin therapy.
Mühlhauser I; Overmann H; Bender R; Jörgens V; Berger M
Diabet Med; 2000 Oct; 17(10):727-34. PubMed ID: 11110506
[TBL] [Abstract][Full Text] [Related]
18. The 10-year incidence of renal insufficiency in people with type 1 diabetes.
Klein R; Klein BE; Moss SE; Cruickshanks KJ; Brazy PC
Diabetes Care; 1999 May; 22(5):743-51. PubMed ID: 10332675
[TBL] [Abstract][Full Text] [Related]
19. The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial.
Diabetes; 1996 Oct; 45(10):1289-98. PubMed ID: 8826962
[TBL] [Abstract][Full Text] [Related]
20. HDL Cholesterol as a Residual Risk Factor for Vascular Events and All-Cause Mortality in Patients With Type 2 Diabetes.
Sharif S; van der Graaf Y; Nathoe HM; de Valk HW; Visseren FL; Westerink J;
Diabetes Care; 2016 Aug; 39(8):1424-30. PubMed ID: 27222511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
